Primary adrenocortical carcinoma: a case report

被引:0
作者
Neupane, Durga [1 ]
Khadka, Sarada [2 ,5 ]
Upadhyaya, Paricha [3 ]
Sah, Suresh P. [1 ]
Dulal, Soniya [4 ]
Shah, Siddhartha K. [1 ]
Shah, Ujjwal K. [1 ]
机构
[1] BP Koirala Inst Hlth Sci, Dept Surg, Dharan, Nepal
[2] BP Koirala Inst Hlth Sci, Dept Surg Breast Endocrine & Gen Surg, Dharan, Nepal
[3] BP Koirala Inst Hlth Sci, Dept Pathol, Dharan, Nepal
[4] BP Koirala Inst Hlth Sci, Dept Internal Med Med Oncol, Dharan, Nepal
[5] BP Koirala Inst Hlth Sci, Dharan 56700, Nepal
关键词
case report; primary adrenocortical carcinoma; chemotherapy; tumor; ADRENAL MASS; CT;
D O I
10.1097/MS9.0000000000000097
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction:Adrenal tumors are very common, affecting 3-10% of the human population, and most are small, benign, nonfunctional adrenocortical adenomas. Adrenocortical carcinoma (ACC), in contrast, is a very rare disease. The median age of diagnosis is in the fifth to sixth decade. There is a predilection for the female gender (the ratio of female to male ranges from 1.5 to 2.5 : 1) the adult. Case presentation:A 28-year-old man who had no prior history of systemic hypertension or diabetes mellitus presented with bilateral limb swelling for 2 months and facial puffiness for 1 month. He had an episode of hypertensive emergencies. A radiological and hormonal work-up established the diagnosis of primary ACC. One cycle of chemotherapy was given until he lost follow-up and succumbed to death due to financial constraints. Conclusions:Adrenocortical carcinoma is an extremely uncommon tumor of the adrenal gland, and it is even more uncommon when it manifests without any symptoms. If patients exhibit signs of rapid and multiple adrenocortical hormone excess, such as weakness, hypokalaemia, or hypertension, ACC may be suspected. Recently developed gynecomastia in men may be brought on by an ACC producing too much sex hormone. To accurately diagnose the condition and give the patient a fair prognosis, a multidisciplinary approach involving endocrine surgeons, oncologists, radiologists, and internists is advised. Proper genetic counseling is recommended. It is critical to know whether the adrenal mass is malignant or not, and to get this ascertained by a computed tomography finding and biopsy.
引用
收藏
页码:1834 / 1838
页数:5
相关论文
共 16 条
[1]   The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines [J].
Agha, Riaz A. ;
Franchi, Thomas ;
Sohrabi, Catrin ;
Mathew, Ginimol ;
Kerwan, Ahmed ;
Thoma, Achilles ;
Beamish, Andrew J. ;
Noureldin, Ashraf ;
Rao, Ashwini ;
Vasudevan, Baskaran ;
Challacombe, Ben ;
Perakath, Benjamin ;
Kirshtein, Boris ;
Ekser, Burcin ;
Pramesh, C. S. ;
Laskin, Daniel M. ;
Machado-Aranda, David ;
Miguel, Diana ;
Pagano, Duilio ;
Millham, Frederick H. ;
Roy, Gaurav ;
Kadioglu, Huseyin ;
Nixon, Iain J. ;
Mukhejree, Indraneil ;
McCaul, James A. ;
Ngu, James Chi-Yong ;
Albrecht, Joerg ;
Gomez Rivas, Juan ;
Raveendran, Kandiah ;
Derbyshire, Laura ;
Ather, M. Hammad ;
Thorat, Mangesh A. ;
Valmasoni, Michele ;
Bashashati, Mohammad ;
Chalkoo, Mushtaq ;
Teo, Nan Zun ;
Raison, Nicholas ;
Muensterer, Oliver J. ;
Bradley, Patrick James ;
Goel, Prabudh ;
Pai, Prathamesh S. ;
Afifi, Raafat Yahia ;
Rosin, Richard David ;
Coppola, Roberto ;
Klappenbach, Roberto ;
Wynn, Rolf ;
De Wilde, Rudy Leon ;
Surani, Salim ;
Giordano, Salvatore ;
Massarut, Samuele .
INTERNATIONAL JOURNAL OF SURGERY, 2020, 84 :226-230
[2]   Clinical review: Adrenocortical carcinoma: Clinical update [J].
Allolio, Bruno ;
Fassnacht, Martin .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (06) :2027-2037
[3]   Prognostic parameters of metastatic adrenocortical carcinoma [J].
Assie, Guillaume ;
Antoni, Guillemette ;
Tissier, Frederique ;
Caillou, Bernard ;
Abiven, Gwenaelle ;
Gicquel, Christine ;
Leboulleux, Sophie ;
Travagli, Jean-Paul ;
Dromain, Clarisse ;
Bertagna, Xavier ;
Bertherat, Jerome ;
Schlumberger, Martin ;
Baudin, Eric .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (01) :148-154
[4]   Adrenocortical Carcinoma: The Range of Appearances on CT and MRI [J].
Bharwani, Nishat ;
Rockall, Andrea G. ;
Sahdev, Anju ;
Gueorguiev, Maria ;
Drake, William ;
Grossman, Ashley B. ;
Reznek, Rodney H. .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2011, 196 (06) :W706-W714
[5]   Adrenocortical Carcinoma [J].
Else, Tobias ;
Kim, Alex C. ;
Sabolch, Aaron ;
Raymond, Victoria M. ;
Kandathil, Asha ;
Caoili, Elaine M. ;
Jolly, Shruti ;
Miller, Barbra S. ;
Giordano, Thomas J. ;
Hammer, Gary D. .
ENDOCRINE REVIEWS, 2014, 35 (02) :282-326
[6]   Clinical management of adrenocortical carcinoma [J].
Fassnacht, Martin ;
Allolio, Bruno .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (02) :273-289
[7]   Limited Prognostic Value of the 2004 International Union Against Cancer Staging Classification for Adrenocortical Carcinomas [J].
Fassnacht, Martin ;
Johanssen, Sarah ;
Quinkler, Marcus ;
Bucsky, Peter ;
Willenberg, Holger S. ;
Beuschlein, Felix ;
Terzolo, Massimo ;
Mueller, Hans-Helge ;
Hahner, Stefanie ;
Allolio, Bruno .
CANCER, 2009, 115 (02) :243-250
[8]   Adrenal Mass Imaging with Multidetector CT: Pathologic Conditions, Pearls, and Pitfalls [J].
Johnson, Pamela T. ;
Horton, Karen M. ;
Fishman, Elliot K. .
RADIOGRAPHICS, 2009, 29 (05) :1333-U162
[9]   Extent of disease at presentation and outcome for adrenocortical carcinoma: Have we made progress? [J].
Kebebew, E ;
Reiff, E ;
Duh, QY ;
Clark, OH ;
McMillan, A .
WORLD JOURNAL OF SURGERY, 2006, 30 (05) :872-878
[10]   CLINICAL-FEATURES OF ADRENOCORTICAL CARCINOMA, PROGNOSTIC FACTORS, AND THE EFFECT OF MITOTANE THERAPY [J].
LUTON, JP ;
CERDAS, S ;
BILLAUD, L ;
THOMAS, G ;
GUILHAUME, B ;
BERTAGNA, X ;
LAUDAT, MH ;
LOUVEL, A ;
CHAPUIS, Y ;
BLONDEAU, P ;
BONNIN, A ;
BRICAIRE, H .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (17) :1195-1201